Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of severe hidradenitis suppurativa with anakinra.

Literature DB >> 23966107

Successful treatment of severe hidradenitis suppurativa with anakinra.

Kian Zarchi¹, Deirdre Nathalie Dufour, Gregor B E Jemec.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2013 PMID： 23966107 DOI： 10.1001/jamadermatol.2013.5377

Source DB: PubMed Journal: JAMA Dermatol ISSN： 2168-6068 Impact factor: 10.282

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

Review 1. [Hidradenitis suppurativa/acne inversa: An update].

Authors: J Kirschke; S Hessam; F G Bechara
Journal: Hautarzt Date: 2015-06 Impact factor: 0.751

Review 2. An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors: I E Deckers; E P Prens
Journal: Drugs Date: 2016-02 Impact factor: 9.546

3. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis.

Authors: Derek Jones; Anirban Banerjee; Peter Z Berger; Alexandra Gross; Sean McNish; Richard Amdur; Victoria K Shanmugam
Journal: Immunol Invest Date: 2017-10-03 Impact factor: 3.657

4. Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.

Authors: Natalie Z Sun; Teresa Ro; Puneet Jolly; Christopher J Sayed
Journal: J Clin Aesthet Dermatol Date: 2017-09-01

Review 5. Treating inflammation by blocking interleukin-1 in humans.

Authors: Charles A Dinarello; Jos W M van der Meer
Journal: Semin Immunol Date: 2013-11-23 Impact factor: 11.130

Review 6. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors: Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal: J Am Acad Dermatol Date: 2019-03-11 Impact factor: 15.487

Successful treatment of severe hidradenitis suppurativa with anakinra.

Review 1. [Hidradenitis suppurativa/acne inversa: An update].

Review 2. An Update on Medical Treatment Options for Hidradenitis Suppurativa.

3. Inherent differences in keratinocyte function in hidradenitis suppurativa: Evidence for the role of IL-22 in disease pathogenesis.

4. Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa.

Review 5. Treating inflammation by blocking interleukin-1 in humans.

Review 6. North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Review 7. Update on hidradenitis suppurativa: connecting the tracts.

Review 8. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Review 9. Review of Current Immunologic Therapies for Hidradenitis Suppurativa.

10. A link between osteomyelitis and IL1RN and IL1B polymorphisms-a study in patients from Northeast Brazil.